Medicare

News

PhRMA is challenging the Trump administration's GLOBE model for Most-Favoured Nation pricing in Medicare Part B in a US district court.

News

CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.

Market Access

While the scope of the revised pilot is limited, it may be a harbinger for a broader policy shift.

Market Access

Hogan Lovells partner Alice Valder Curran returned to elucidate some of the finer points of the latest communication from CMS.

News

Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.

News

An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.